Stock Update (NYSE:LLY): Lilly to Present at J.P. Morgan Healthcare Conference

[PR Newswire] – INDIANAPOLIS, Jan. 4, 2016 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will present at the 34 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016. John C. Lechleiter, Ph.D., … Read more on this. Eli Lilly and Company (LLY) , valued at $87.91B, started the session at $83.40. Looking at the equity, the company’s one day range is $82.54 to $83.40 with its 52-week range being $68.31 to $92.85. LLY shares are currently priced at 24.49x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -3.61x forward p/e ratio. And for dividend hunters, the company pays shareholders $2.04 per share annually in dividends, yielding 2.42%. Consensus earnings for the current quarter by the 18 sell-side analysts covering the stock is an estimate of $0.78 per share, which would be $0.03 better than the year-ago quarter and a $0.00 sequential decrease. The full-year EPS estimate is $3.44 which would be a $0.66 better than last year’s full-year earnings. The quarterly earnings estimate is predicated on a consensus revenue forecast of $5.33 Billion. If reported, that would be a 4.10% increase over the year-ago quarter. More recently, BMO Capital Markets upgraded LLY from Market Perform to Outperform (Nov 13, 2015). Previously, Credit Suisse upgraded LLY from Neutral to Outperform. Given all the information above, we should disclose to readers that the average price target is $99.85, which is 19.72% above than it opened this morning. See more in (NYSE:LLY) Similar Articles: Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly Sets Dates and Conference Calls for 2016 Financial Guidance and Fourth-Quarter 2015 Financial Results Market Update (NYSE:LLY): Lilly to Participate in Morgan Stanley Global Healthcare Conference Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly to End Contract with the University of California, San Diego for A4 Alzheimer’s Study